Home/Pipeline/Minimal Residual Disease (MRD) Testing

Minimal Residual Disease (MRD) Testing

Post-treatment Cancer Monitoring

Commercial/ValidationLDT Service

Key Facts

Indication
Post-treatment Cancer Monitoring
Phase
Commercial/Validation
Status
LDT Service
Company

About Burning Rock Biotech

Burning Rock Biotech's mission is to 'Guard Life via Science' by becoming a new pillar in the international healthcare industry. The company has established itself as a leader in China's precision oncology diagnostics market, with a portfolio of CE-marked kits, a CLIA/CAP-certified lab, and a U.S. FDA Breakthrough Device designation. Its strategy is built on a dual business model of selling IVD products and providing LDT services, while strategically investing in R&D for early cancer detection and a nascent therapeutic pipeline to drive long-term growth.

View full company profile

Therapeutic Areas